It has been found that the insulin-like growth factor receptor (IGF-1R)/AKT/mTOR and the mevalonate-isoprenoid biosynthesis pathways were upregulated in CRC stem cells (CSCs), inducing tumor cell growth and proliferation. The gene discussed is AKT1; the disease is colorectal carcinoma.